| The emerging landscape of single-molecule protein sequencing technologies JA Alfaro, P Bohländer, M Dai, M Filius, CJ Howard, XF Van Kooten, ... Nature methods 18 (6), 604-617, 2021 | 241 | 2021 |
| Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ... Nature genetics 46 (11), 1166-1169, 2014 | 221 | 2014 |
| The proteogenomic landscape of curable prostate cancer A Sinha, V Huang, J Livingstone, J Wang, NS Fox, N Kurganovs, ... Cancer Cell 35 (3), 414-427. e6, 2019 | 192 | 2019 |
| Onco-proteogenomics: cancer proteomics joins forces with genomics JA Alfaro, A Sinha, T Kislinger, PC Boutros Nature methods 11 (11), 1107-1113, 2014 | 144 | 2014 |
| ABO (H) blood group A and B glycosyltransferases recognize substrate via specific conformational changes JA Alfaro, RB Zheng, M Persson, JA Letts, R Polakowski, Y Bai, ... Journal of biological chemistry 283 (15), 10097-10108, 2008 | 108 | 2008 |
| Highly conserved homotrimer cavity formed by the SARS-CoV-2 spike glycoprotein: a novel binding site U Kalathiya, M Padariya, M Mayordomo, M Lisowska, J Nicholson, ... Journal of clinical medicine 9 (5), 1473, 2020 | 85 | 2020 |
| Detecting protein variants by mass spectrometry: a comprehensive study in cancer cell-lines JA Alfaro, A Ignatchenko, V Ignatchenko, A Sinha, PC Boutros, T Kislinger Genome medicine 9, 1-12, 2017 | 62 | 2017 |
| Glycosyltransferase structure and function B Schuman, JA Alfaro, SV Evans Bioactive Conformation I, 217-257, 2007 | 51 | 2007 |
| Nonsense-mediated mRNA decay: pathologies and the potential for novel therapeutics K Pawlicka, U Kalathiya, J Alfaro Cancers 12 (3), 765, 2020 | 40 | 2020 |
| Sampling the proteome by emerging single-molecule and mass spectrometry methods MJ MacCoss, JA Alfaro, DA Faivre, CC Wu, M Wanunu, N Slavov nature methods 20 (3), 339-346, 2023 | 39 | 2023 |
| Mass spectrometry-based identification of MHC-associated peptides S Kote, A Pirog, G Bedran, J Alfaro, I Dapic Cancers 12 (3), 535, 2020 | 36 | 2020 |
| Aberrant DNA methylation reprogramming during induced pluripotent stem cell generation is dependent on the choice of reprogramming factors AC Planello, J Ji, V Sharma, R Singhania, F Mbabaali, F Müller, JA Alfaro, ... Cell regeneration 3, 1-14, 2014 | 34 | 2014 |
| Proteomic profiling of secreted proteins, exosomes, and microvesicles in cell culture conditioned media A Sinha, S Principe, J Alfaro, A Ignatchenko, V Ignatchenko, T Kislinger The Surfaceome: Methods and Protocols, 91-102, 2018 | 25 | 2018 |
| Functional interfaces, biological pathways, and regulations of interferon-related DNA damage resistance signature (IRDS) genes M Padariya, A Sznarkowska, S Kote, M Gómez-Herranz, S Mikac, M Pilch, ... Biomolecules 11 (5), 622, 2021 | 24 | 2021 |
| Characterization of protein content present in exosomes isolated from conditioned media and urine A Sinha, J Alfaro, T Kislinger Current Protocols in Protein Science 87 (1), 24.9. 1-24.9. 12, 2017 | 18 | 2017 |
| Insights into the effects of cancer associated mutations at the UPF2 and ATP-binding sites of NMD master regulator: UPF1 U Kalathiya, M Padariya, K Pawlicka, CS Verma, D Houston, TR Hupp, ... International journal of molecular sciences 20 (22), 5644, 2019 | 16 | 2019 |
| Sequence-dependent effects of cryoprotectants on the active sites of the human ABO (H) blood group A and B glycosyltransferases AR Johal, B Schuman, JA Alfaro, S Borisova, NOL Seto, SV Evans Acta Crystallographica Section D: Biological Crystallography 68 (3), 268-276, 2012 | 14 | 2012 |
| MicroPOTS analysis of Barrett’s esophageal cell line models identifies proteomic changes after physiologic and radiation stress K Weke, A Singh, N Uwugiaren, JA Alfaro, T Wang, TR Hupp, JR O’Neill, ... Journal of Proteome Research 20 (5), 2195-2205, 2021 | 13 | 2021 |
| Recognition dynamics of cancer mutations on the ERp57-tapasin interface M Padariya, U Kalathiya, DR Houston, JA Alfaro Cancers 12 (3), 737, 2020 | 12 | 2020 |
| FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer M Canel, AD Sławińska, DW Lonergan, AA Kallor, R Upstill-Goddard, ... Gut 73 (1), 131-155, 2024 | 11 | 2024 |
